|
|
|
1 Department of Cell Biology and Anatomy, and 2 Department of Neurology and Neuroscience, Cornell University Medical College, New York, New York 10021; 3 Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021; 4 Brookdale Center for Molecular Biology, Mt. Sinai School of Medicine, New York, New York 10029
| |
Abstract |
|---|
|
|
|---|
During development of the central nervous system, oligodendrocyte progenitor cells (O-2A) undergo an orderly pattern of cell proliferation and differentiation, culminating in the ability of oligodendrocytes to myelinate axons. Here we report that p27Kip1, a cyclin-dependent kinase inhibitor, is an important component of the decision of O-2A cells to withdraw from the cell cycle. In vitro, accumulation of p27 correlates with differentiation of oligodendrocytes. Furthermore, only a fraction of O-2A cells derived from p27-knockout mice differentiate successfully compared to controls. Inability to differentiate correlates with continued proliferation, suggesting that p27 is an important component of the machinery required for the G1/G0 transition in O-2A cells. In vivo, expansion of O-2A precursors before withdrawal, in part, leads to a greater number of oligodendrocytes. Together these data indicate a role for p27 during the decision to withdraw from the cell cycle in the oligodendrocyte lineage.
[Key Words: Oligodendrocyte progenitor cells; cell proliferation; differentiation; CKI p27Kip1]
| |
Introduction |
|---|
|
|
|---|
Differentiation of cells requires withdrawal from the cell cycle
and induction of a novel program of gene expression leading to
elaboration of a specialized phenotype (Hofbauer and Denhardt 1991
;
Duronio and O'Farrell 1994
; Lassar et al. 1994
; Boulikas 1995
). This process requires inductive signals from
the environment coincident with or after cell cycle withdrawal. Failure
to coordinate growth arrest and differentiation may result in a failure
to form normal tissues because cells either continue to proliferate
(Kipreos et al. 1996
) or undergo apoptosis (Boudreau et al. 1996
).
Furthermore, growth arrest within the context of differentiation may be
separated into two events: one in which the proliferating cell
withdraws from the cell cycle to allow changes in gene expression and
the other in which the differentiated cell is prevented from reentering the cell cycle. It is unclear what changes in the expression of cell
cycle regulatory molecules reflects the establishment of the growth
arrest state, or its maintenance, or both.
Progression of a cell through G1 and into S phase is
dependent on the coordinated activation of two cyclin-dependent kinases (CDKs), CDK4/6 and CDK2 (Resnitzky and Reed 1995
; Sherr
and Roberts 1995
). Interference of either kinase is sufficient to lead
to growth arrest because regulatory networks coordinate CDK activity and entry into S phase (Koff 1995
). Activation of each kinase is a
highly regulated process beginning with the association of a CDK
subunit with a positive regulatory subunit, cyclin E with CDK2 (Koff et
al. 1992
) and cyclin D with CDK4/6 (Matsushime et al.
1992
; Xiong et al. 1992
; Meyerson and Harlow 1994
), and followed by
phosphorylation of the CDK subunit by the CDK-activating kinase (Fisher
and Morgan 1994
; Matsuoka et al. 1994
). The activation process may be
regulated negatively by other phosphorylation events on the CDK subunit
(Morgan 1995
) and by the interaction of the cyclin/CDK
complex with other proteins (Sherr and Roberts 1995
), specifically the
CDK inhibitors (CKI), Inks (p15, p16, p18, and p19), and Kips (p21,
p27, and p57). Ink proteins are specific inhibitors of the cyclin
D/CDK complex and interfere with the activity either in
ternary complexes (Reynisdóttir et al. 1997
) or by competing with
cyclin D for the CDK subunit (Hirai et al. 1995
). Kip proteins are
strong inhibitors of both CDKs in vitro (Harper et al. 1993
; Polyak et
al. 1994
; Toyoshima and Hunter 1994
; Lee et al. 1995
; Matsuoka et al.
1995
). However, p27 may be more selective for CDK2 compared to CDK4 in
vivo (Soos et al. 1996
; Hauser et al. 1997
). The solution of ternary
cyclin A/CDK2/p27 crystals suggests that
p27 prevents ATP access or the ability to coordinate ATP (Russo et al.
1996
).
Differentiation is associated with a reduction in the overall amount of
G1 CDK activity. Ectopic expression of D-type cyclins can
prevent differentiation in some cell lines derived from muscle (Skapek
et al. 1995
) and hematopoietic (Kato and Sherr 1993
) lineages. Reciprocally, the introduction of p21 or p27 into neuronal (Kranenburg et al. 1995
), hematopoietic (Liu et al. 1996
), and muscle (Guo et al.
1995
) precursor cells enhances their differentiation. Consistent with
these observations, the accumulation of CKIs has been noted in many
terminally differentiated cell types in mice (Matsuoka et al. 1995
;
Parker et al. 1995
). Expression of p21 mRNA is greatest in the liver,
muscle, and epithelium of the intestine and stomach, and p57 mRNA
levels are highest in the kidney, muscularis mucosae in the stomach,
and muscle. p27 mRNA expression studies are of limited utility as
post-transcriptional mechanisms regulate the expression of this protein
(Pagano et al. 1995
; Agrawal et al. 1996
; Hengst and Reed 1996
; Millard
et al. 1997
). We and others detected p27 protein in a subset of
developing thymocytes (Hoffman et al. 1996
), in neurons (Lee et al.
1996
), in luteal cells of the ovary (Kiyokawa et al. 1996
), in mature
T-cells (Firpo et al. 1994
), and in protein extracts from all organ
systems
although not necessarily in all cell types in each tissue
(Kiyokawa et al. 1996
; Nakayama et al. 1996
). Consistent with a role in
the development of all organs, mice deficient for the CDK inhibitory function of p27 display enhanced growth (Fero et al. 1996
; Kiyokawa et
al. 1996
; Nakayama et al. 1996
). Growth is not attributable to
alterations in the level of growth hormones, insulin-like growth factor
I (IGF-I) and IGF-II, or adrenocorticotropic hormone (ACTH), endocrine
factors known to affect large numbers of target tissues. Rather, growth
correlates with an increase in the percentage of cycling cells in
tissues undergoing maturation, suggesting that loss of p27 might lead
to additional cell divisions before withdrawal from the cell cycle
(Kiyokawa et al. 1996
). However, it was unclear whether the increase in
proliferation was a consequence of failure to withdraw from the cell
cycle and differentiate in a timely fashion. No obvious cell cycle
defects were observed in fibroblasts obtained from embryonic
p27
/
mice (Fero et al. 1996
; Nakayama et al.
1996
). Recently, others have described hyperproliferative phenotypes in
Caenorhabditis elegans and Drosophila melanogaster and have mapped these to the cul-1 (Kipreos et al. 1996
) and
dacapo (Lane et al. 1996
) loci, respectively. Although there
is no significant homology between cul-1 and p27,
dacapo has strong homology in the
cyclin/CDK-binding domain. Consistent with this, the loss of function phenotypes are more similar for dacapo and p27
than for cul-1 and p27.
O-2A bipotential precursor cells have the capacity to differentiate
into either oligodendrocytes or astrocytes (Temple and Raff 1985
; Raff
1989
). These cells can be isolated from the cortex of neonatal mice and
maintained in a proliferative state in medium conditioned by the B104
neuroblastoma cell line (Temple and Raff 1985
; Barres et al. 1994
;
Casaccia-Bonnefil et al. 1996
). Addition of basal fibroblast growth
factor (bFGF) and platelet-derived growth factor (PDGF) can replace the
B104-conditioned medium. O-2A cells are identified readily by bipolar
morphology, reactivity to A2B5 antibodies (Raff et al. 1983
), and
reactivity to NG2 antibodies (Nishiyama et al. 1996
). In vitro, in the
presence of thyroid hormone and mitogens, these cells divide and the
amount of p27 increases with each division; eventually, the cells stop
proliferating and differentiate into oligodendrocytes (Durand et al.
1997
). In addition, culture of O-2A cells in serum-free conditions with thyroid hormone induces growth arrest and differentiation into oligodendrocytes (Barres et al. 1994
). Oligodendrocytes are detected as
cells with highly branched processes that express myelin basic protein
(MBP) and galactocerebroside (GalC) (Raff et al. 1983
), but do not
express NG2 (Nishiyama et al. 1996
).
CG-4 cells, an immortalized cell line derived from a bipotential rat
O-2A cell, differentiate along the type II astrocyte lineage when
deprived of conditioned medium but maintained in serum (Louis et al.
1992
). Differentiation correlated with accumulation of p27 and a
concomitant loss of cyclin E/CDK2 kinase activity suggesting that p27 may play an important role in the commitment decision of glial progenitors (Tikoo et al. 1997
). However, these cells
differentiated poorly into oligodendrocytes and we were unable to
address whether p27 had an obligatory role in oligodendrocyte differentiation.
To investigate the consequence of loss of p27 function in the glial
lineage, we followed the differentiation of O-2A cells obtained from
p27
/
mice into oligodendrocytes. We report that under conditions that promote differentiation of wild-type cells, cells
obtained from p27
/
mice have impaired growth
arrest after mitogen removal. This defect in growth arrest was not
sufficient to eliminate the oligodendrocyte lineage as a fraction of
cells continue to form oligodendrocytes morphologically
indistinguishable from those of wild-type cells. Impaired growth arrest
correlated with continued progression of O-2A cells into S-phase,
directly demonstrating for the first time that p27 is part of the
circuitry deciding whether cells should commit to the cell cycle or
withdraw
the restriction point. Consistent with the hypothesis that
continued cycling of the O-2A cells will expand the number of
precursors before differentiation, we detected a substantial increase
in the number of oligodendrocytes and type I astrocytes in animals early in postnatal development. This correlated with increased MBP and
proteolipid (PLP) production. These data suggest that p27 is an
important component of the machinery that regulates withdrawal of O-2A
cells during G1 traverse.
| |
Results |
|---|
|
|
|---|
p27 expression correlates with withdrawal of O-2A cells from the cell cycle
Environmental signals control the decision of cells to commit to a
round of cell division or withdraw from the cell cycle and undergo
differentiation. The commitment decision is regulated positively by the
activity of G1 CDKs and negatively by the concentration of
stoichiometric CDK inhibitory proteins Inks and Kips (Sherr and Roberts
1995
). To determine the changes in the cell cycle machinery that occur
during mitogen withdrawal-induced differentiation of O-2A cells into
oligodendrocytes, we examined the expression of various cyclins, CDKs,
and CKI during differentiation of primary O-2A precursors.
We obtained O-2A precursor cells by selective shaking of mixed glial
cultures and maintained them in a proliferative state by culturing in
B104-conditioned medium (McCarthy and DeVellis 1980). More than 90% of
the shaken cells were identified positively as oligodendrocyte
precursors on the basis of their characteristic bipolar morphology and
immunoreactivity with the O-2A markers A2B5 and NG2. The contaminating
cells were MBP- and glial fibrillary acidic protein (GFAP)-positive
astrocytes. After 5 days of serum-free culture in the presence of
thyroid hormone, 90-95% of the cells had a highly branched
morphology, were not reactive with either A2B5 or NG2 antibodies, and
were reactive with GalC (O1)- and MBP-specific antibodies. These cells
were classified as oligodendrocytes (Casaccia-Bonnefil et al. 1996
).
After differentiation to oligodendrocytes, we examined the expression of G1 CDKs (CDK2, CDK4, CDK5), CKIs (p16, p21, p27), and cyclins (D-type cyclins and cyclin E) by immunoblotting. Overall the amount of CDK2 and CDK4 and all G1 cyclins decreased, whereas the amounts of CDK5, p21, and p27 increased (Fig. 1A). The level of p16 did not change (Fig. 1A). These data suggest that in agreement with the CG-4 cell model, the differentiation of primary glial precursors correlates with increased expression of the CDK inhibitor p27 and a loss of G1 cyclins and CDKs. Together these events might conspire to establish the nonproliferative state, maintain the nonproliferative state, or both.
|
To determine whether p27 was involved in either the establishment of growth arrest, or its maintenance (or both), we examined the expression of p27 and CDK2 protein during the differentiation process and correlated this with the expression of an oligodendroycte differentiation marker GalC. Expression of p27 was lowest in the proliferating O-2A cells, maximal the first day of serum-free culture, and decreased thereafter (Fig. 1B). On the other hand, we observed a rapid loss of CDK2 and its expression remained low throughout the time course. As a control for protein loading we measured the amount of actin. Consistent with the rapid increase in p27 and loss of CDK2, we found that after 24 hr in serum-free medium the percentage of cycling cells, as judged by incorporation of bromodeoxyuridine (BrdU), dropped from 80% ± 11% (n = 6) to 15.2% ± 1.6% (n = 3) within a day and was at its lowest by 5 days (n = 3). We detected GalC in 2.6% ± 2% of the cycling precursor cell population (n = 6) and this did not increase concomitantly with growth arrest. At 24 hr (n = 3) only 3.5 ± 1.8% of the cells were GalC positive. However, after 5 days of serum deprivation 87 ± 1.2% of the cells were positive (n = 3). Together these data suggest that the increase in p27 represented an early event establishing withdrawal of cells from the cell cycle.
Commitment decisions in O-2A precursors deficient of p27
These data suggested that p27 might participate in establishing
growth arrest of O-2A cells. Previous work from our laboratory reported
that mice lacking p27 displayed an increase in the number of many cell
types, attributable in part to an increase in the proliferation of
cells undergoing postnatal maturation (Fero et al. 1996
; Kiyokawa et
al. 1996
; Nakayama et al. 1996
). However, we were unable to demonstrate
that the increase in S-phase cells, in either developing thymocytes or
the cells of the intermediate lobe of the pituitary, occurred by
altering the efficiency of the G1
G0
transition. Consequently, we investigated the process of O-2A cell
differentiation further to determine whether loss of p27 affects the
commitment function. Does the loss of p27 lead to inappropriate
proliferation at the expense of differentiation?
We obtained mixed glial cultures from cortical dissections of neonatal
mice and after 7-10 days of culture we separated O-2A precursors from
the type I astrocytes by differential shaking. Equal numbers of O-2A
cells from wild-type and knockout animals were plated and induced to
differentiate by withdrawing mitogens. First, we determined the
percentage of cycling cells by BrdU labeling the day of isolation. At
the beginning of the experiment, a greater percentage of
p27
/
cells passed through S-phase over a 6-hr period (Table 1; Fig. 2a,b; p27
/
,
n = 3; p27+/+, n = 5),
suggesting that the loss of p27 increased the fraction of S-phase
cells. We did not detect a change
in cell size (cf. the phase contrast in Fig. 2c,d). To confirm that the
cycling cells were O-2A precursors and not a novel cell type
specifically enriched in p27
/
cultures, we
double-stained cells for BrdU and NG2, a marker for O-2A precursors. Of
the BrdU positive cells, 85-90% were also NG2 positive indicating that they were O-2A precursors (Fig. 2e,f).
|
|
Next, we measured the proliferation of cells 5 days after withdrawing mitogens. By this time, there was a dramatic decrease in the proportion of cycling cells in the wild-type cultures, which did not occur in the cultures derived from p27-deficient mice (Table 1; Fig. 3a,b). The majority of cells in the wild-type culture were differentiated oligodendrocytes as determined by the following three criteria: (1) they did not incorporate BrdU (Fig. 3c); (2) they displayed a highly branched morphology (Fig. 4a,c); and (3) they were MBP positive (Fig. 5k).
|
|
|
In contrast, there were three distinct cell types in
p27
/
cultures: bipolar cells, small round cells
growing either isolated or in cultures (Figs. 4, b and d, and 5, a and
c), and highly branched cells with elaborate processes (Fig. 4b; Fig.
5f). Of these cell types, only the bipolar and small round cells
incorporated BrdU (Fig. 3d). To determine the identity of these cells,
we examined the expression of NG2 and MBP, markers of O-2A precursors
and oligodendrocytes, respectively. The highly branched cells that did
not incorporate BrdU were unreactive to NG2 antiserum and expressed MBP
consistent with identification as oligodendrocytes (Fig. 5i-k). The
small round cells bearing few or no processes labeled with the anti-NG2
antibody and were unreactive to the MBP antibody (Fig. 5a-h),
consistent with identification as oligodendrocyte precursors. Some of
these cells incorporated BrdU and some did not. In summary, although it
is clear, by both morphological and immunocytochemical criteria, that
the BrdU-positive cells are O-2A precursors that failed to
differentiate, the BrdU-negative and NG2-positive cells might represent
an early stage of oligodendrocyte differentiation or a population of
cells in which differentiation was delayed.
Next, we assessed the percentage of differentiated cells in wild-type
and p27
/
cultures kept for 5 days after mitogen
withdrawal by counting the number of O-2A precursors (NG2-positive
cells bearing no or few processes) and mature oligodendrocytes (highly branched MBP-positive cells). In wild-type cultures, only a small fraction were precursors (Table 2). In contrast,
p27
/
cultures consisted predominantly of O-2A
precursors (Table 2). We conclude that in p27
/
cultures the majority of cells were still at a precursor stage and the
ability of p27
/
cells to withdraw from the cell
cycle was perturbed. Regardless, it is clear that the commitment event
was not abrogated completely by p27 disruption as some cells did
differentiate. We speculate that p27 is only part of the commitment
machinery and that other events such as the down-regulation of CDK2
might be involved.
|
Increased numbers of glial cells in p27
/
mice
Next, we examined the numbers of neuronal and glial cells in the
brain of p27
/
mice. To accomplish this we
examined sagittal brain sections of adult mice
(p27
/
, n = 3;
p27+/+, n = 3) and counted the
numbers of cells expressing either mitogen-associated protein 2 (MAP2)
or GFAP, markers of neuronal and astrocytic cells, respectively.
Consistent with the reports of others, the numbers of MAP2-staining
neurons in the CA1 region of the hippocampus increased 30% ± 8%.
The numbers of GFAP-staining cells, type I astrocytes, was
250% ± 10% higher in the hippocampus and in the cerebellum of
the same animals.
It is difficult to quantitate the numbers of oligodendrocytes in these
regions of adult brain because available antibodies stain the cell
processes and not the nucleus. To circumvent this problem we counted
the number of toluidine blue staining cells in 1 µM
transverse sections of the optic nerve cut 1 mm in front of the optic
chiasm in both p27
/
and control mice (Fig.
6). Glial cell bodies are the primary cell type in
this region of the optic nerve. We quantitated the cell number in
random fields of several sections. Surprisingly, in 6-day-old mice
(n = 4) the number of glial cells was 262% ± 31%
higher than in controls; however, at 9 weeks (n = 8)
glial cells were only 50% ± 10% greater in
p27
/
compared to controls. Consequently, the loss
of p27 led to an increase in the numbers of glial cells in vivo.
|
The finding that oligodendrocyte differentiation efficiency was decreased in vitro, but oligodendrocyte number increased in vivo might be explained by either accumulation of oligodendrocytes that do not express MBP in vivo (what we define as nonfunctional), or increased proliferation of the O-2A precursor pool before differentiation. To address these alternatives we examined the expression of MBP in adult mouse brain and the numbers of O-2A cells.
Myelination in p27-deficient mice
To address the functional state of oligodendrocytes we examined
MBP expression by Western blot and immunohistochemistry. We prepared
crude brain homogenates and measured the steady state amount of
myelin-specific proteins MBP and PLP by immunoblotting after
normalization of proteins by weight. In p27
/
mice
both MBP and PLP increased in the membrane fractions (Fig.
7). This increase might reflect either increased
numbers of functional oligodendrocytes or increased biosynthetic
activity of the oligodendrocytes.
|
Consistent with Western blotting, we observed increased MBP
immunoreactivity in brain sections from 6-day-old wild-type and p27
/
mice (n = 3 for each group).
We observed an increase in MBP expression in the brainstem and
cerebellum (data not shown). Similarly, we observed increased MBP
immunoreactivity in 9-week-old animals (n = 4 for each
group) (Fig. 8). Electron micrographs of the optic
nerve revealed normal patterns of myelination (data not shown).
Together these data suggest that oligodendrocytes formed in
p27
/
mice were normal with regard to myelination.
|
Another possibility was that the absence of p27 may affect
neuronal/glial communication making the oligodendrocytes
less dependent on neuronal survival signals. However, this is unlikely
because we observed apoptotic cells in electron micrographs from the
6-day-old optic nerve of p27
/
mice (Fig. 6c) and
numbers of glial cells normalized to neuronal number by 9 weeks. This
observation is consistent with the proposal that the number of
oligodendrocytes is determined by axonal contact in the optic nerve
(Raff et al. 1993
; Burne et al. 1996
) and in the absence of these
factors oligodendrocytes are likely to be eliminated by programmed cell
death. Together these data suggest that oligodendrocytes formed in
p27
/
mice are normal with regard to their
requirement for neuronal survival factors.
The increase in oligodendrocytes is attributed to an increase in the number of precursor cells
Another mechanism that may explain the early postnatal increase in
oligodendrocyte number is an expansion of the O-2A precursor population. In this case, the reduction in differentiation efficiency with continued cycling, observed in vitro, might lead to an increase in
the size of the precursor pool in vivo. To address whether the number
of O-2A precursor cells was affected in p27
/
mice, we counted the O-2A and type I astrocytes in mixed glial cultures obtained from the brains of animals. We identified O-2A precursors in
the mixed glial cultures by three criteria: (1) positive staining for
A2B5; (2) distinctive bipolar morphology; and (3) the absence of
reactivity to antibodies specific for GFAP and GalC. Cultures obtained
from p27
/
mice had a sevenfold increase in O-2A
precursors compared to wild-type mice (p27
/
,
n = 6; p27+/+, n = 10)
(Fig. 9). In addition, the numbers of GFAP-staining
cells, representing type I astrocytes, increased 2.8-fold. The
magnitude of this increase was similar to that observed for the
astrocytes counted in sagittal brain sections. Consequently, the loss
of p27 affects the proliferation of O-2A cells, both in vivo and in
vitro.
|
| |
Discussion |
|---|
|
|
|---|
Growth arrest and differentiation of muscle, neuronal, and
hematopoietic cells require down-regulation of CDK activities (Kato and
Sherr 1993
; Guo et al. 1995
; Kranenburg et al. 1995
; Skapek et al.
1995
; Liu et al. 1996
). O-2A precursor cells differentiate to
oligodendrocytes either by following an intrinsic counting mechanism
that is coupled to cell division ("intrinsic clock") (Raff et al.
1985
, 1988
), or by removing the mitogens required for continued
proliferation (Barres et al. 1994
). Recently, in cells undergoing the
intrinsic program, Durand and colleagues (1997) correlated
oligodendrocyte differentiation with an increase in p27 protein. At
present, we demonstrate that the CDK inhibitor p27 facilitates the
differentiation of oligodendrocytes; in the absence of p27, O-2A cells
differentiate poorly when deprived of mitogens. The failure to
differentiate correlated with continued cycling of O-2A precursor cells
leading to an expansion of these cells. In vivo we detected myelinated
axons and an increase in the amount of myelin components, attributable
to an increase in the number of oligodendrocytes. The discrepancy,
vis-á-vis terminal differentiation, between the in vivo and in
vitro observations can be reconciled by postulating that an increase
in O-2A precursors (as a result of increased cycling before terminal
differentiation) occurs in vivo, and that the in vitro conditions are
not able to substitute fully for inductive or survival signals
normally present in vivo. In addition to delayed withdrawal of the
O-2A precursor, increased seeding of the O-2A compartment by a
progenitor cell also impacts on the number of O-2A precursors (P. Casaccia-Bonnefil, M.V. Chao, and A. Koff, unpubl.). Hence, we can
conclude that p27 plays an important role establishing growth arrest
to allow differentiation in mitogen-deprived O-2A cells, and that
other pathways impinge on this process. These results indicate for the first time that loss of p27 affected proliferation of cells at the
expense of differentiation. Hence, p27 is involved in the machinery
that controls withdrawal of cells from the cell cycle, at least in O-2A
cells.
p27 is likely to be an effector of the differentiation program of oligodendrocytes
In O-2A cells, precursors to oligodendrocytes, differentiation may
be induced either by withdrawing mitogens, or by an intrinsic program
(a "clock") that is activated after a discrete number of
divisions. The clock postulates the existence of a molecular component that can count the number of divisions. The "counter" is linked to an effector, which initiates cell cycle arrest and differentiation. The relationship between these pathways is obscure and
mitogens might suppress the effector, rather than being on a completely
distinct pathway. The similarities of the clock and replicative
senescence, and of mitogen withdrawal to G1 arrest make O-2A
cells an attractive model for studying the roles of CKI in
differentiation. There is a substantial amount of data supporting
the involvement of the p16 and p21 proteins in senescence (Noda et al.
1994
; Stein and Dulic 1995
; Tahara et al. 1995
; Hara et al. 1996
).
Thus, we predict that the clock might incorporate pathways shared by
p16 and p21. Furthermore, we predict that if the clock and mitogen
pathways are related, the effector component of the clock would be
shared between the mechanisms.
Of three CDK inhibitors we measured during oligodendrocyte
differentiation, only p27 expression was changed dramatically. We were
surprised that we did not observe a change in p16 levels as mutation of
p16 is associated with malignant glioma and the overexpression of p16
can prevent U87 glioblastoma proliferation (Medema et al. 1995
; Poulos
et al. 1996
). The lack of an increase in p16 suggests that it may be
involved in mediating the intrinsic program. The intrinsic program
relies on the experimental observation that O-2A cells divide a limited
number of times before differentiating into oligodendrocytes (Barres et
al. 1994
; Bögler and Noble 1994
). This is reminiscent of cells
undergoing a programmed senescence and suggests that those proteins
involved in senescence, such as p21 and p16 (Noda et al. 1994
; Stein
and Dulic 1995
; Tahara et al. 1995
; Hara et al. 1996
), may play a
greater role in the establishment of growth arrest and terminal
differentiation by the intrinsic mechanism.
Several approaches have concluded that p27 levels increase during
oligodendrocyte differentiation (this study; Durand et al. 1997
).
Durand et al. (1997)
have shown that p27 levels are elevated as O-2A
cells age in culture, correlating with the eventual cessation of growth
and ultimately, differentiation of cells. Furthermore, we have shown
that mitogen withdrawal correlates with induction of p27, cessation of
growth and differentiation, and the absence of p27 affects the process
of growth arrest. To accomodate these observations we suggest that p27
might be a nodal point where the differentiation of oligodendrocytes,
whether by mitogen-induced or intrinsically programmed pathways, come
together (Fig. 10). We speculate that p27 is part of
the effector mechanism, and that mitogens suppress the induction of the
p27 and block the clock program, suggesting that other changes in the
cell cycle
or the machinery that controls p27 expression
might be the
actual counting mechanism.
|
The role of p27 in oligodendrocyte differentiation
Consistent with an important role for p27 in the differentiation
of oligodendrocytes we observe that this process is perturbed in the
O-2A cells obtained from p27
/
mice. At a time
when growth arrest and differentiation occur in wild-type cultures, a
large proportion of cells obtained from p27
/
mice
are still cycling, as evidenced by incorporation of BrdU. Other cells
have clearly withdrawn from the cell cycle but have not elaborated
markers specific to the oligodendrocyte lineage, such as MBP, and a
small percentage have stopped dividing and undergo differentiation. Although we are unable to establish the direct linkage between these
three cell types, it seems likely that the "noncycling, MBP-negative, NG2-positive" cells are delayed in differentiation (Gard and Pfeiffer 1989
, 1990
), and the culture conditions used may not
provide sufficient factor to sustain these cells longer. Alternatively,
these cells might represent a differentiation dead-end, one not
normally observed because p27 prevents cells from embarking on this
pathway.
If the loss of p27 delays the eventual withdrawal of cells from the
cell cycle, then one predicts that there would be an expansion of
precursor cells before differentiation. This expansion might allow an
increase in the number of cells elaborating the terminally differentiated phenotype in the animal. Consistent with this, we
observed an increased number of oligodendrocytes in the optic nerve in
vivo and increased myelination in the optic nerve (data not shown) and
in other regions of the central nervous system. Perhaps in vivo other
signals acting on other p27-independent pathways preserve the
differentiation functions not preserved in the in vitro system.
Ultimately, homeostatic mechanisms can normalize cell number in organ
systems. For example, neuronal cells may provide inductive stimuli. It
has been proposed that the number of oligodendrocytes is determined by
axonal contact providing signals that promote their growth and survival
(Raff et al. 1993
).
The studies in O-2A cells documented here suggest that p27 is an
important component of the commitment machinery. p27 may operate within
the cell cycle to establish the rate of G1 passage and
alterations in G1 duration can affect the ability of cells to
respond to anti-mitogenic signals that withdraw cells from the cell
cycle. Overexpression of Cln3 in yeast (Cross 1988
), overexpression of
cyclin E in mammalian cells (Ohtsubo and Roberts 1993), cul-1
deficiencies in C. elegans (Kipreos et al. 1996
), deficiency
of p27 in mice (Fero et al. 1996
; Kiyokawa et al. 1996
; Nakayama et al.
1996
), deficiency of p27 in 3T3 fibroblasts (Coats et al. 1996
), and
deficiency of dacapo, a p27-related CDK inhibitor in
Drosophilia (Lane et al. 1996
), diminish the response of cells to environmental signals. Thus, the gain of rate-limiting regulators of
S-phase entry, the cyclins, and the loss of p27 yield similar proliferation and differentiation phenotypes. However, overexpression of cyclins or deletion of cul-1 also affects cell size,
whereas the loss of p27 or dacapo do not, suggesting that the
cyclins and p27 might have discrete as well as overlapping functions. We speculate that p27 might be rate limiting for withdrawal from the
cell cycle, and communication between rate-limiting cyclins and
rate-limiting p27 occurs as the cells traverse the restriction point.
Consistent with this, p27 is both a substrate and an inhibitor of the
cyclin E-associated kinase (Sheaff et al. 1997
). It is tempting to
speculate that growth arrest eventually occurs in p27
/
mice because down-regulation of
cyclin/CDK2 occurs, allowing cells to default into the
differentiation program. Elucidation of epistasis relationships between
the various cyclins and inhibitors will clarify this process further.
| |
Materials and methods |
|---|
|
|
|---|
Cell culture
Primary cortical cultures (postnatal day zero) of O-2A precursors were obtained by differential shaking of mixed glial cultures that were kept in M15 media (MEM containing 15% fetal calf serum) for 7 days. Immediately after shaking, precursor cells were plated on poly-lysine coated dishes in M15 medium. After 6-18 hr, precursor cells were either kept proliferating in MM medium [DMEM containing 30% B104-conditioned medium + N1 supplements (50 µg/ml of transferrin, 16 µg/ml of putrescine, 60 ng/ml of progesterone, 50 ng/ml of selenium, and 5 µg/ml of insulin)] or differentiated to oligodendrocytes in differentiation medium, consisting of BME:F12 (1:1) supplemented with 100 µg/ml of transferrin, 20 µg/ml of putrescine, 12.8 ng/ml of progesterone, 10.4 ng/ml of selenium, 25 µg/ml of insulin, 0.8 µg/ml of thyroxine, 0.6% glucose, and 6.6 mM glutamine. After the shake-off, astrocytes (GFAP+) were maintained in M15 medium.
Bromodeoxyuridine incorporation
Cells were given a 6-hr pulse with 10 µM
5-bromo-2
-deoxyuridine and then fixed in ice cold
acetone/methanol (1:1). After 30 min in 1 N
HCl, cells were incubated in anti-BrdU antibody (1:100) in
PBS + 0.3% Tween 20 + 3% horse serum at 4°C overnight. After 1 hr of incubation at room temperature in anti-mouse secondary antibody solution (1:500 in PBS), cells were stained using
Vectastain Elite ABC, according to manufacturer's instructions, and
visualized using diaminobenzidine as substrate.
Cell extracts
Cells were detached from culture plates by scraping, and then
collected in Hank's salt solution (GIBCO). Cells were washed in PBS,
and then resuspended in HKM buffer [30 mM HEPES-KOH (pH 7.4), 7.5 mM MgCl2], 0.5 mM
dithiothreitol (DTT), 2 mM PMSF, 5 µg/ml of
leupeptin, and 3.5 µg/ml of aprotinin. After lysis by sonication, cells were subjected to centrifugation to separate the cell
pellet. Protein extracts were adjusted to 0.1 N NaCl and then
stored at
70°C.
Tissue extracts
Immediately after dissection, a 10% brain homogenate was obtained in PBS containing 320 mM sucrose and protease inhibitors. The homogenate was subjected to low speed centrifugation (10 min at 800g at 4°C) and the supernatant spun for 20 min at 9000g at 4°C. The pellet was then resuspended in PBS containing freshly prepared protease inhibitors and further spun at 165,000g for 120 min at 4°C to obtain membrane (pellet) and cytosolic (supernatant) fractions.
Western blotting
Protein extracts (20-100 µg/lane) were
analyzed by SDS-polyacrylamide gel electrophoresis. Proteins were
transferred to a polyvinylidene fluoride (PVDF) membrane. The membrane
was then blocked with 5% nonfat milk (Carnation) and incubated with
primary antibodies. Most antibodies were obtained from Santa Cruz,
except for p27 (Soos et al. 1996
), anti-MBP, and anti-PLP (gift from Drs. L. Pedraza and D. Colman, Rockefeller University, New York, NY).
After incubating with anti-rabbit or anti-mouse horseradish peroxidase-conjugated secondary antibody
(Boehringer/Mannheim), proteins were visualized using an
enhanced chemiluminescence system (Amersham).
Immunocytochemistry/immunohistochemistry
Cells were fixed for 10 min at room temperature in 4% paraformaldehyde in PBS (pH 7.4). Brains were fixed in 4% paraformaldehyde in PBS (pH 7.4) for 12-16 hr at 4°C, dehydrated, and then paraffin embedded. Ten-micrometer sections were deparaffinized and then processed for immunohistochemistry. Primary antibodies were used at 1:500 for NG2 (a gift from Joel Levine, Mt. Sinai School of Medicine, New York, NY), 1:2000 for GFAP (Dako Corporation), 1:250 for MAP2 (Boehringer/Mannheim), and 1:2000 for MBP (a gift from Liliana Pedraza). For A2B5 and GalC staining, the antibodies were used undiluted on live cells for 30 min at room temperature and then fixed in 4% paraformaldehyde. After 1 hr of incubation at room temperature in secondary antibody solution, cells were stained using Vectastain Elite ABC, according to manufacturer's instructions, and visualized using diaminobenzidine as substrate.
Electron microscopy
Optic nerves were immersion fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) at 4°C for 12-16 hr and then postfixed in 1% OsO4, 1.5% K4Fe(CN)6 in 0.1 M cacodylate buffer for 1 hr at 4°C. After serial dehydration steps in alcohol, samples were embedded in Epon. Semithin sections (1 µm) were cut exactly 1 mm anterior to the optic chiasm and stained with toluidine blue. Glial cell nuclei were counted. Ultrathin sections (60 nm) were cut in a Sorvall MT5000 ultramicrotome, using a Diatome diamond knife (Diatome, Fort Washington, PA). Sections were stained with lead citrate and examined in a JEOL 100 CX II electron miroscope (JEOL, USA, Peabody, MA) operating at 80 Kv and photographed on Kodak 4489 electron microscope film.
| |
Acknowledgments |
|---|
This work was supported in part by the National Institutes of Health (NIH) grants HD232315 and NS21072 to MVC and CA68425 and GM52597 to A.K. A.K. is also supported by a Pew Scholarship in Biomedical Sciences and the Frederick R. Adler Chair for Junior Faculty. This work was also supported by fellowships from the NIH (P.C.B.), the Charles Revson Foundation (R.T.), the DeWitt Wallace Research Fund of Memorial Sloan-Kettering Cancer Center (H.K.), and the Dorothy Rodbell Foundation (M.V.C.). We thank Joel Levine, Liliana Pedraza, and David Colman for generously providing antibodies; Leigh Cohen-Gould and Dilruba Khanam for technical assistance; and Martin Raff for communicating unpublished results. In addition, we thank the Sloan-Kettering Institute Cell Cycle Group for their advice during the course of this work.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received April 18, 1997; revised version accepted July 21, 1997.
5 Corresponding author.
E-MAIL a-koff{at}ski.mskcc.org; FAX (212) 639-2861.
| |
References |
|---|
|
|
|---|
and O4+GalC
) under different mitogenic control.
Neuron
5:
615-625[CrossRef][Medline].
-chain gene rearrangement: Coincident regulation of cell cycle and clonality during development in vivo.
Genes & Dev.
9:
948-962.